Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death.
Gupta
Sanjay
S
Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Milbrandt
Eric B
EB
Chelluri
Lakshmipathi
L